Sanofi Aktie
103,28EUR | 0,84EUR | 0,82% |
WKN: 920657 / ISIN: FR0000120578
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 90,65 |
Plan d'Epargne Entreprise Sanofi Synthelabo | 1,80 |
Sanofi | 0,79 |
Caisse de Dépôt & Placement du Québec | 0,59 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 106 566 | 104 226 | 100 409 | 99 412 | 95 442 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,33 | 0,33 | 0,36 | 0,36 | 0,40 |
Bilanz (in Mio. EUR) - Aktiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 26 352 | 24 579 | 28 611 | 33 703 | 30 564 |
Summe Anlagevermögen | 73 690 | 83 516 | 84 867 | 86 676 | 91 095 |
Summe Aktiva | 99 826 | 111 408 | 112 736 | 114 529 | 120 242 |
Bilanz (in Mio. EUR) - Passiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 15 601 | 24 640 | 25 933 | 23 675 | 22 414 |
Summe Fremdkapital | 41 568 | 52 373 | 53 628 | 51 382 | 51 211 |
Summe Eigenkapital | 58 258 | 59 035 | 59 108 | 63 147 | 69 031 |
Summe Passiva | 99 826 | 111 408 | 112 736 | 114 529 | 120 242 |
Adresse
54, rue La Boétie, 75008 Paris | |
Telefon | +33 (1) 53-77-40-00 |
Fax | +33 (1) 53-77-44-03 |
Internet | http://www.sanofi.com |
Management
Alexandra Roger
Head-Securities Law & Capital Markets |
Arnaud Delépine
Investor Relations Officer |
Arnaud Robert
Chief Digital Officer & Executive Vice President |
Barbara Lavernos
Independent Director |
Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs |
Christophe Babule
Director |
Claire Terrazas
Vice President-Corporate Legal Affairs |
Diane D. Souza
Independent Director |
Dietmar P. Berger
Chief Medical Officer & Global Head-Development |
Eva Schäfer-Jansen
Investor Relations Contact |
Fabienne Lecorvaisier
Independent Director |
Gilles Schnepp
Independent Director |
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President |
John C. Reed
EVP & Global Head-Research & Development |
Josep Catlla
Head-Communication |
Julie van Ongevalle
Executive VP & Head-Consumer Healthcare |
Lise Kingo
Independent Director |
Natalie Bickford
Chief People Officer & Executive Vice President |
Nestle Frank
Global Head-Immunology Therapeutic Research Area |
Noel Geoffroy
Head-North America Consumer Healthcare |
Olivier Antoine M. Charmeil
Executive Vice President-General Medicines |
Patrick Kron
Independent Director |
Paul Hudson
Chief Executive Officer & Director |
Rachel Duan
Independent Non-Executive Director |
Raj Verma
Chief Diversity, Culture & Experience Officer |
Roy Papatheodorou
General Counsel |
Serge Weinberg
Chairman |
Thomas C. Südhof
Independent Director |
William J. Sibold
Executive Vice President-Sanofi Genzyme |
Wolfgang Laux
Director |
Yann Tran
Director |